Breaking News
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
Video conferencing helps PCPs improve liver disease care, survival rates

Video conferencing helps PCPs improve liver disease care, survival rates

image_pdfDownload PDFimage_print
Providing physicians with virtual access to specialists can be lifesaving to liver disease patients. A new study by Michigan Medicine finds that it boosts survival rates by 54 percent. Credit: Michigan Medicine/Manifest

For patients who live in rural areas, driving to see a specialist in a large city or at a university hospital can be challenging, if not impossible.

And yet, it’s a necessity for better health: People with liver disease often require multiple visits to adjust medications or treat related complications.

“I’ve always been frustrated when I can’t help patients who live in distant areas and don’t have a car or money for transportation,” says University of Michigan gastroenterologist Grace L. Su, M.D. who is chief of gastroenterology at the VA Ann Arbor Healthcare System.

Even when a patient is able to see his or her local primary care physician, problems could arise. Those practitioners may have knowledge gaps, little to no communication with the patient’s specialist or time constraints that lead to poor quality care.

That divide is especially personal for Su.

After one of her patients died after he couldn’t return for a follow-up visit, she turned frustration into action by researching how technology could be applied to reach more rural patients and their doctors.

In a study published in Hepatology, Su and her team affirmed that communication is key: Patients of primary care physicians who participated in video consultations with liver disease specialists had a 54 percent higher survival rate than patients whose primary doctors didn’t participate in those exchanges.

“Primary care providers really want to do the right thing, but they may not have all the necessary tools,” says Su. “This research shows an excellent way to impart specialty knowledge to them. The learning is mutual. They are not just learning; they are teaching us.”

Joining forces via video

Such thinking isn’t new. Years ago, researchers at the University of New Mexico developed the Extension of Community Healthcare Outcome (ECHO) program to train primary care providers to treat hepatitis C in patients living in rural and remote areas.

The Veterans Health Administration adopted this “telementoring” model and renamed the program Specialty Care Access Network-Extension of Community Healthcare Outcome (SCAN-ECHO). The VA Ann Arbor Healthcare System was one of the first organizations to utilize the SCAN-ECHO program for chronic liver disease.

Using vital records provided by the Veterans Health Administration, researchers learned that there were 62,237 veteran patients with liver disease in Michigan, central Indiana and northwest Ohio between 2011 to 2015.

Of that group, only 513 patients had a primary care physician who engaged in a SCAN-ECHO consultation about their case.

During those consultations, videoconferencing was used to link primary care providers and specialists. The individual patient cases were discussed and treatment plans and recommendations were made in real time. Patients whose cases were chosen to receive video consultation were more likely to be younger, live in rural areas and have more severe liver disease, including evidence of cirrhosis.

Participating doctors benefit along with the patients.

“It is one thing to for a primary care provider to read or learn about a disease, but another when they have a specific patient in mind. This case-based teaching magnifies the potential for learning. Creating many mini-specialists from primary care providers is the most powerful aspect of the SCAN-ECHO program,” says Su, who directs the SCAN-ECHO clinics at the Ann Arbor VA. “It’s a medical force multiplier.”

Present limits, future potential

The new research had some limitations. Providers who voluntarily did the virtual consultations may have had a strong interest in improving their skills and learning more, but direct comparisons couldn’t be made from the two groups. Information about patients’ socioeconomic status was also unavailable.

Instead, researchers adjusted for distance, illness severity, demographics and comorbidities.

But it seems that doctor involvement in the video conferencing is why patients survived longer.

“It does not appear to be a patient compliance issue since the program is not a direct specialist-to-patient interaction but one between specialists and primary care providers,” says Su. “It seems that primary care providers who participated in the SCAN-ECHO were more likely to follow the guidelines for cirrhosis and perform the screening for esophageal varicose veins and liver cancer in the patients who need it.” “I think it is the behavior of the provider that’s the reason patients lived longer.”

Future research will involve determining if the primary care providers are applying the knowledge learned from the SCAN-ECHO program to other patients who were not enrolled in the program.

Although the Veterans Health Administration is a fully integrated health care system that treats a unique population, Su notes that similar video consultation programs could benefit any situation where specialty care and primary care providers need to partner up—especially when distance is a factor.

“Video consultation is the future of medicine,” says Su. “Our only other alternative is to send specialists to rural areas, and that’s not going to happen.”


Explore further:
Program equips rural primary care providers to manage complex diabetes

More information:
Grace L Su et al, Virtual Consultations through the Veterans Administration SCAN-ECHO Project Improves Survival for Veterans with Liver Disease, Hepatology (2018). DOI: 10.1002/hep.30074

Journal reference:
Hepatology

Provided by:
University of Michigan

Tagged with:

About author

Related Articles